Your browser doesn't support javascript.
loading
In vitro and in silico evaluations of actinomycin X2and actinomycin D as potent anti-tuberculosis agents.
Qureshi, Kamal Ahmad; Azam, Faizul; Fatmi, Muhammad Qaiser; Imtiaz, Mahrukh; Prajapati, Dinesh Kumar; Rai, Pankaj Kumar; Jaremko, Mariusz; Emwas, Abdul-Hamid; Elhassan, Gamal Osman.
Afiliación
  • Qureshi KA; Department of Pharmaceutics, Unaizah College of Pharmacy, Qassim University, Unaizah, Al-Qassim, Saudi Arabia.
  • Azam F; Department of Pharmaceutical Chemistry and Pharmacognosy, Unaizah College of Pharmacy, Qassim University, Unaizah, Al-Qassim, Saudi Arabia.
  • Fatmi MQ; Department of Biosciences, COMSATS University Islamabad, Islamabad, Pakistan.
  • Imtiaz M; Department of Biosciences, COMSATS University Islamabad, Islamabad, Pakistan.
  • Prajapati DK; Department of Biotechnology, Faculty of Biosciences, Invertis University, Bareilly, Uttar Pradesh, India.
  • Rai PK; Department of Biotechnology, Faculty of Biosciences, Invertis University, Bareilly, Uttar Pradesh, India.
  • Jaremko M; Smart-Health Initiative (SHI) and Red Sea Research Center (RSRC), Division of Biological and Environmental Sciences and Engineering (BESE), King Abdullah University of Science and Technology (KAUST), Thuwal, Jeddah, Saudi Arabia.
  • Emwas AH; Core Labs, King Abdullah University of Science and Technology (KAUST), Thuwal, Saudi Arabia.
  • Elhassan GO; Department of Pharmaceutics, Unaizah College of Pharmacy, Qassim University, Unaizah, Al-Qassim, Saudi Arabia.
PeerJ ; 11: e14502, 2023.
Article en En | MEDLINE | ID: mdl-36935926

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tuberculosis Resistente a Múltiples Medicamentos / Antituberculosos Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tuberculosis Resistente a Múltiples Medicamentos / Antituberculosos Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article